F
Francisco Forriol
Researcher at CEU San Pablo University
Publications - 159
Citations - 3720
Francisco Forriol is an academic researcher from CEU San Pablo University. The author has contributed to research in topics: Cartilage & Anterior cruciate ligament. The author has an hindex of 32, co-authored 152 publications receiving 3362 citations. Previous affiliations of Francisco Forriol include Complutense University of Madrid & University of Navarra.
Papers
More filters
Journal ArticleDOI
Nonunion: general principles and experimental data.
TL;DR: The main experimental data regarding the knowledge ofNonunions and the basic methods that may be applied to the treatment of nonunions are reviewed.
Journal ArticleDOI
Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial.
William D. Stanish,Robert G. McCormack,Francisco Forriol,Nicholas G. H. Mohtadi,Stéphane Pelet,Jacques Desnoyers,Alberto Restrepo,Matthew S. Shive +7 more
TL;DR: BST-CarGel treatment resulted in greater lesion filling and superior repair tissue quality compared with microfracture treatment alone, and clinical benefit was equivalent between groups at twelve months, and safety was similar.
Journal ArticleDOI
Footprint analysis between three and seventeen years of age.
Francisco Forriol,Jose Pascual +1 more
TL;DR: A high percentage of lowered longitudinal medial arch in the youngest age group of the study was found, and the percentage is lower in the older age groups.
Journal ArticleDOI
Distraction Osteogenesis of the Lower Extremity with Use of Monolateral External Fixation. A Study of Two Hundred and Sixty-one Femora and Tibiae*
TL;DR: The results of the present review suggest that the use of healing indices to gauge the final outcome of distraction osteogenesis is questionable and was unable to discern significance or clinical importance from appropriately adjusted values.
Journal ArticleDOI
BST-CarGel® Treatment Maintains Cartilage Repair Superiority over Microfracture at 5 Years in a Multicenter Randomized Controlled Trial.
Matthew S. Shive,William D. Stanish,Robert G. McCormack,Francisco Forriol,Nicholas G. H. Mohtadi,Stéphane Pelet,Jacques Desnoyers,Stéphane Méthot,Kendra Vehik,Alberto Restrepo +9 more
TL;DR: BST-CarGel® was shown to be an effective mid-term cartilage repair treatment and resulted in sustained and significantly superior repair tissue quantity and quality over microfracture alone at 5 years.